在当代支气管镜检查中,阿特罗平和氧预处理的影响
Kazuo Tsuchiya1, Ryota Miyamoto1, Tomo Tsunoda1
1Department of Respiratory Medicine, Shizuoka Saiseikai General Hospital, 1-1-1 Oshika, Shizuoka City, Shizuoka, 422-8527, Japan.
Respiratory investigation
|November 21, 2025
概括
支气管镜检查前用抗胆固醇药物预治疗可以减少患者从分泌物和咳中产生的不适. 这种方法可能会改善患者的舒适性和愿意重复手术而不会产生不良影响,因此需要进一步研究.
科学领域:
- 肺部病理学 肺部病理学
- 麻醉学 麻醉学
- 医疗程序 医疗程序
背景情况:
- 支气管镜对于诊断呼吸系统疾病至关重要,但可以通过分泌物和呼吸道反射来限制.
- 抗胆性药物预治疗历来能够控制这些反应,但由于安全性和有效性的担忧,目前的指导方针对其常规使用提出了质疑.
- 这项研究重新评估了抗胆固醇预治疗在现代支气管镜检查实践中的有效性.
研究的目的:
- 为了评估抗胆固醇前期治疗在缓解支气管镜检查期间患者不适的有效性.
- 为了比较预先治疗和未预先治疗的支气管镜队列之间的手术结果和患者报告的经验.
主要方法:
- 一个单一中心的横截面研究比较了两组35名经过支气管镜检查的患者与活检.
- 组A接受了肌肉内氨酸和氧氨酸预治疗;组B没有.
- 倾向性得分调整与治疗权重的逆概率 (IPTW) 用于控制基线差异.
主要成果:
- 在IPTW调整后,未预先治疗的组 (B组) 报告说,唾液和咳的痛苦显著增加.
- B组的患者对重复支气管镜检查的意愿也较低,利多卡因的使用率也较高.
- 两组之间没有观察到米达佐拉姆剂量或生命体征的显著差异.
结论:
- 抗胆固醇药物预治疗似乎可以减少与支气管透视期间分泌物和呼吸道反射有关的手术不适.
- 这些发现表明,对患者的舒适性和重复手术的接受性有潜在的好处,没有显著的不良影响.
- 需要进一步的随机对照试验来证实抗胆固醇预治疗在当代支气管镜术中的作用.
相关概念视频
Cholinergic Antagonists: Therapeutic Uses
1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K
Antiasthma Drugs: Muscarinic Receptor Antagonists
1.6K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.6K
Cholinergic Antagonists: Pharmacokinetics
885
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
885
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
864
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
864
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.5K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.5K


